CPRX vs SHOP · P/E 18, rev $491.7M vs P/E 107, rev $3.58B
Catalyst Pharmaceuticals Inc (CPRX) versus Shopify Inc (SHOP) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Shopify Inc (SHOP) is a software - application company listed on US. It is led by Tobi Lutke.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Latest reported SHOP revenue for 2026-06-30 was $3.58B. Net income was $1.50B. Revenue was up 13.0% from 2026-03-31 to 2026-06-30. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
Not investment advice. Open the CPRX and SHOP stock pages for the full models.
Not investment advice.